Blood Reviews
Volume 17, Issue 3 , Pages 163-166 , September 2003

Hematopoietic stem cell transplantation in sickle cell disease

  • Christiane Vermylen

      Affiliations

    • Corresponding Author InformationCorrespondence to: Christiane Vermylen MD, PhD, Department of Pediatric Hematology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Avenue Hippocrate 10, B - 1200 Brussels, Belgium. Tel.: +32-2-764-25-50; Fax: +32-2-764-89-64

References 

  1. Serjeant GR. Natural history and determinants of clinical severity of sickle cell disease. Curr. Opin. Hematol. 1995;2:103–108
  2. Miller ST, Sleeper LA, Pegelow CH, et al.  Prediction of adverse outcomes in children with sickle cell disease. N. Engl. J. Med. 2000;342:83–89
  3. Platt OS, Brambilla DJ, Rosse WF, et al.  Mortality in sickle cell disease: life expectancy and risk factors for early death. N. Engl. J. Med. 1994;330:1639–1644
  4. Vichinsky E, Styles L. Sickle cell disease: pulmonary complications. Hematol. Oncol. Clin. North Am. 1996;10:1275–1287
  5. Wong W, Elliot-Mills D, Powars D. Renal failure in sickle cell anemia. Hematol. Oncol. Clin. North Am. 1996;10:1321–1331
  6. Kinney T, Ware R. The adolescent with sickle cell anemia. Hematol. Oncol. Clin. North Am. 1996;10:1255–1264
  7. Charache S, Terrin ML, Moore RD, et al.  The Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 1995;332:1317–1322
  8. Ferster A, Tahriri P, Vermylen C, et al.  Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001;97:3628–3632
  9. Walters MC, Patience M, Leisenring W, et al.  Bone marrow transplantation for sickle cell anemia. N. Engl. J. Med. 1996;335:369–376
  10. Walters MC, Patience M, Leisenring W, et al.  Barriers to bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant. 1996;2:100–104
  11. Kodish E, Lantos J, Stocking C, et al.  Bone marrrow transplantation for sickle cell disease. A study of parent’s decisions. N. Engl. J. Med. 1991;325:1349–1353
  12. Walters MC, Patience M, Leisenring W, et al.  Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol. Blood Marrow Transplant. 2001;7:665–673
  13. Van Besien K, Bartholomew A, Stock W, et al.  Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant. 2000;26:445–449
  14. Schleuning M, Stoetzer O, Waterhouse C, Schlemmer M, Ledderose G, Kolb HJ. Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp. Hematol. 2002;30:7–10
  15. Krishnamurti L, Blazar BR, Wagner JE. Bone marrow transplantation without myeloablation for sickle cell disease. N. Engl. J. Med. 2001;344:68
  16. Horan J, Liesveld J, Rochon P et al. Hematopoietic stem cell transplantation for sickle cell disease and thalassemia after low dose TBI, fludarabine and rabbit ATG. Washington, DC: National Sickle Cell Disease Program 2002
  17. Vermylen C, Fernandez Robles E, Ninane J, Cornu G. Bone marrow transplantation in five children with sickle cell anaemia. Lancet. 1988;1:1427–1428
  18. Vermylen C, Cornu G. Hematopoietic stem cell transplantation for sickle cell anemia. Curr. Opin. Hematol. 1997;4:377–380
  19. Vermylen C, Cornu G, Ferster A, et al.  Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998;22:1–6
  20. Bernaudin F, Souillet G, Vannier JP, et al.  Report of the French experience concerning 26 children transplanted for severe sickle cell disease. Bone Marrow Transplant. 1997;19(suppl 2):112–115
  21. Hoppe CC, Walters MC. Bone marrow transplantation in sickle cell anemia. Curr. Opin. Oncol. 2001;13:85–90
  22. Borgna-Pignatti C, Marradi P, Rugolotto S, Marcolongo A. Succesful pregnancy after bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1996;18:235–236
  23. Ferster A, Bujan W, Corazza F, et al.  Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood. 1993;81:1102–1105
  24. Walters MC, Storb R, Patience M, et al.  Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood. 2000;95:1918–1924
  25. Gaziev D, Galimberti M, Lucarelli G, et al.  Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant. 2000;25:815–821
  26. La Nasa G, Giardini C, Argiolu F, et al.  Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood. 2002;99:4350–4356
  27. Petersdorf EW, Hansen JA, Martin PJ, et al.  Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N. Engl. J. Med. 2001;345:1794–1800
  28. Petersdorf EW, Kollman C, Hurley CK, et al.  Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood. 2001;98:2922–2929
  29. Ruggeri L, Capanni M, Urbani E, et al.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–2100
  30. Handgretinger R, Klingebiel T, Lang P, et al.  Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 2001;27:777–783
  31. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplant in patients with thalassemia and sickle cell disease. Blood 2003;101:2137–2143 prepublished online Nov 7, 2002
  32. Laughlin MJ, Barker J, Bambach B, et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 2001;344:1815–1822
  33. Grigg AP. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/β+-thalassemia. Blood. 2001;97:3998–3999
  34. Addler BK, Salzman DE, Carabasi MH, et al.  Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood. 2001;97:3313–3314
  35. Kang EM, Areman EM, David-Ocampo V, et al.  Mobilization, collection and processing of peripheral blood stem cells in individuals with sickle cell trait. Blood. 2002;99:850–855

PII: S0268-960X(03)00006-7

doi: 10.1016/S0268-960X(03)00006-7

Blood Reviews
Volume 17, Issue 3 , Pages 163-166 , September 2003

Article Tools